Chengdu Olymvax Biopharmaceuticals Inc. (688319.SS)
CNY 15.98
(-0.06%)
CNY 15.98
(-0.06%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.04 CNY | -34.6% |
| 2022 | 0.07 CNY | -75.7% |
| 2021 | 0.27 CNY | 363.92% |
| 2020 | 0.06 CNY | 175.98% |
| 2019 | -0.08 CNY | 17.1% |
| 2018 | -0.09 CNY | 28.92% |
| 2017 | -0.13 CNY | 55.17% |
| 2016 | -0.29 CNY | 6.45% |
| 2015 | -0.31 CNY | -72.22% |
| 2014 | -0.18 CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.00 CNY | 92.51% |
| 2024 Q1 | -0.06 CNY | -200.94% |
| 2024 Q3 | 0.08 CNY | 1743.75% |
| 2023 Q4 | -0.02 CNY | -595.35% |
| 2023 Q3 | 0.00 CNY | -92.94% |
| 2023 FY | - CNY | -34.6% |
| 2023 Q1 | 0.01 CNY | 117.26% |
| 2023 Q2 | 0.06 CNY | 950.0% |
| 2022 Q2 | 0.09 CNY | 666.06% |
| 2022 Q1 | -0.02 CNY | -121.57% |
| 2022 FY | - CNY | -75.7% |
| 2022 Q4 | -0.03 CNY | -249.33% |
| 2022 Q3 | 0.02 CNY | -75.91% |
| 2021 Q2 | 0.05 CNY | -3.57% |
| 2021 Q4 | 0.08 CNY | -12.07% |
| 2021 Q1 | 0.06 CNY | 0.0% |
| 2021 FY | - CNY | 363.92% |
| 2021 Q3 | 0.09 CNY | 61.11% |
| 2020 Q2 | 0.03 CNY | 426.32% |
| 2020 FY | - CNY | 175.98% |
| 2020 Q3 | 0.06 CNY | 110.0% |
| 2020 Q4 | - CNY | -100.0% |
| 2020 Q1 | 0.01 CNY | 121.35% |
| 2019 Q1 | -0.08 CNY | 0.0% |
| 2019 FY | - CNY | 17.1% |
| 2019 Q4 | -0.03 CNY | 0.0% |
| 2018 Q1 | 0.00 CNY | -93.38% |
| 2018 Q2 | 0.00 CNY | 0.0% |
| 2018 FY | - CNY | 28.92% |
| 2017 Q4 | 0.03 CNY | 0.0% |
| 2017 FY | - CNY | 55.17% |
| 2017 Q1 | -0.03 CNY | 65.95% |
| 2017 Q3 | 0.03 CNY | 200.67% |
| 2017 Q2 | -0.03 CNY | 0.0% |
| 2016 Q1 | -0.06 CNY | 39.29% |
| 2016 Q4 | -0.09 CNY | 0.0% |
| 2016 FY | - CNY | 6.45% |
| 2016 Q3 | -0.09 CNY | -60.18% |
| 2016 Q2 | -0.06 CNY | 0.0% |
| 2015 Q3 | -0.09 CNY | -35.22% |
| 2015 Q2 | -0.07 CNY | 0.0% |
| 2015 Q1 | -0.07 CNY | 0.0% |
| 2015 FY | - CNY | -72.22% |
| 2015 Q4 | -0.09 CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |